首页 › 基金 › Rubric Capital Management LP › AMRX
Rubric Capital Management LP 对 AMRX 的持仓历史
AMNEAL PHARMACEUTICALS INC · 医疗保健
Rubric Capital Management LP 在 Q3 2026 的 13F 申报中披露持有 AMRX(AMNEAL PHARMACEUTICALS INC)8,536,755 股,市值约 US$171.9M,约占其申报组合的 1.63%,在其申报持仓中市值排名第 17 位。 Rubric Capital Management LP 最近 13 个申报季度中有 13 个季度披露了 AMRX 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Rubric Capital Management LP 对 AMRX 的持仓演变
Rubric Capital Management LP 于 Q3 2023 首次披露 AMRX 持仓:4,024,500 股(约 US$17.0M)。 该持仓在 Q2 2026 达到峰值 10,168,660 股,市值约 US$176.0M。 在 13 次申报中,Rubric Capital Management LP 5 次增持、3 次减持、4 次保持不变。 最近一期申报(Q3 2026)显示持股 8,536,755 股、市值约 US$171.9M,环比减持 -1,631,905 股。。 持仓曾出现大幅变动:Q4 2023 增持约 99% (随后一个季度股价基本持平)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 4.02M | $16.98M | 新进 |
| Q4 2023 | 8.00M | $48.56M | 增持 |
| Q1 2024 | 9.54M | $57.82M | 增持 |
| Q2 2024 | 10.72M | $68.08M | 增持 |
| Q3 2024 | 10.72M | $89.21M | 持有 |
| Q4 2024 | 10.72M | $84.92M | 持有 |
| Q1 2025 | 10.74M | $89.97M | 持有 |
| Q2 2025 | 11.71M | $94.74M | 增持 |
| Q3 2025 | 12.33M | $123.47M | 增持 |
| Q4 2025 | 12.33M | $155.42M | 持有 |
| Q1 2026 | 11.04M | $137.20M | 减持 |
| Q2 2026 | 10.17M | $176.02M | 减持 |
| Q3 2026 | 8.54M | $171.93M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 AMRX 与 13F 数据
AMRX(AMNEAL PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 47 只申报持有 AMRX,申报仓位最大的包括:TPG GP A, LLC (US$248.3M), Tri Locum Partners LP (US$46.9M), Nantahala Capital Management, LLC (US$42.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 AMRX 的基金
- TPG GP A, LLC 12.33M 股 · $248.30M · Q3 2026
- Tri Locum Partners LP 2.33M 股 · $46.86M · Q3 2026
- Nantahala Capital Management, LLC 2.12M 股 · $42.61M · Q3 2026
- Westshore Wealth, LLC 1.37M 股 · $23.65M · Q2 2026
- PFM Health Sciences, LP 822.89K 股 · $16.57M · Q3 2026
- Phocas Financial Corp. 819.48K 股 · $14.19M · Q2 2026
- Soleus Capital Management, L.P. 658.00K 股 · $13.25M · Q3 2026
更多关于 Rubric Capital Management LP
常见问题
How long has Rubric Capital Management LP held AMRX?
Rubric Capital Management LP has disclosed AMRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Rubric Capital Management LP's current position in AMRX?
As of Q3 2026, Rubric Capital Management LP holds 8.54M shares of AMRX (AMNEAL PHARMACEUTICALS INC), valued at $171.93M, representing 1.63% of its reported portfolio and ranking #17.
Has Rubric Capital Management LP been buying or selling AMRX?
In the latest 13F filing (Q3 2026), Rubric Capital Management LP reduced its position in AMRX. The position peaked in Q2 2026 at 10.17M shares.
Which other funds hold AMRX?
Other major institutional holders of AMRX include TPG GP A, LLC, Tri Locum Partners LP, Nantahala Capital Management, LLC, among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.